Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Body Contouring Devices and Procedures Market

ID: MRFR/MED/15179-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
US Body Contouring Devices and Procedures Market Research Report: Size, Share, Trend Analysis By Procedure Type (Non-invasive, Minimally invasive, Invasive), By Device Type (Laser Devices, Radiofrequency Devices, Cryolipolysis Devices, Ultrasound Devices, Suction Devices), By Applications Area (Abdomen, Thighs, Arms, Back, Submental) and By End Users (Hospitals, Clinics, Medical Spas, Beauty Salons) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Procedure Type (USD Million)
      1. 4.1.1 Non-invasive
      2. 4.1.2 Minimally invasive
      3. 4.1.3 Invasive
    2. 4.2 Life Sciences, BY Device Type (USD Million)
      1. 4.2.1 Laser Devices
      2. 4.2.2 Radiofrequency Devices
      3. 4.2.3 Cryolipolysis Devices
      4. 4.2.4 Ultrasound Devices
      5. 4.2.5 Suction Devices
    3. 4.3 Life Sciences, BY Application Area (USD Million)
      1. 4.3.1 Abdomen
      2. 4.3.2 Thighs
      3. 4.3.3 Arms
      4. 4.3.4 Back
      5. 4.3.5 Submental
    4. 4.4 Life Sciences, BY End User (USD Million)
      1. 4.4.1 Hospitals
      2. 4.4.2 Clinics
      3. 4.4.3 Medical Spas
      4. 4.4.4 Beauty Salons
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Allergan (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Merz Pharmaceuticals (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Hologic (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Revance Therapeutics (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Galderma (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Sientra (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Cynosure (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 InMode (IL)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Cutera (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PROCEDURE TYPE
    3. 6.3 US MARKET ANALYSIS BY DEVICE TYPE
    4. 6.4 US MARKET ANALYSIS BY APPLICATION AREA
    5. 6.5 US MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
    9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    12. 6.12 LIFE SCIENCES, BY PROCEDURE TYPE, 2024 (% SHARE)
    13. 6.13 LIFE SCIENCES, BY PROCEDURE TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 LIFE SCIENCES, BY DEVICE TYPE, 2024 (% SHARE)
    15. 6.15 LIFE SCIENCES, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 LIFE SCIENCES, BY APPLICATION AREA, 2024 (% SHARE)
    17. 6.17 LIFE SCIENCES, BY APPLICATION AREA, 2024 TO 2035 (USD Million)
    18. 6.18 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
    19. 6.19 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY DEVICE TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION AREA, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Life Sciences Market Segmentation

Life Sciences By Procedure Type (USD Million, 2025-2035)

  • Non-invasive
  • Minimally invasive
  • Invasive

Life Sciences By Device Type (USD Million, 2025-2035)

  • Laser Devices
  • Radiofrequency Devices
  • Cryolipolysis Devices
  • Ultrasound Devices
  • Suction Devices

Life Sciences By Application Area (USD Million, 2025-2035)

  • Abdomen
  • Thighs
  • Arms
  • Back
  • Submental

Life Sciences By End User (USD Million, 2025-2035)

  • Hospitals
  • Clinics
  • Medical Spas
  • Beauty Salons